Australia markets open in 8 hours 14 minutes

Zai Lab Limited (ZLAB)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
34.03-0.19 (-0.56%)
As of 11:44AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close34.22
Open34.33
Bid33.72 x 1300
Ask33.78 x 800
Day's range33.58 - 35.00
52-week range22.51 - 178.91
Volume152,236
Avg. volume628,190
Market cap3.332B
Beta (5Y monthly)1.21
PE ratio (TTM)N/A
EPS (TTM)-5.84
Earnings date09 Aug 2022 - 15 Aug 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est98.08
  • GlobeNewswire

    Zai Lab Announces Primary Listing on the Main Board of The Stock Exchange of Hong Kong Limited

    – First company to Convert from Secondary to Primary Listing Status in Hong Kong – Our dual Primary Listing on the Nasdaq and Hong Kong Stock Exchange provides greater access for investors SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., June 27, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced that it has completed its voluntary conversion of its secondary listing status to a p

  • GlobeNewswire

    Zai Lab Announces Breakthrough Therapy Designations Granted for Repotrectinib in China

    -- Breakthrough Therapy Designations granted for ROS1-positive non-small cell lung cancer (NSCLC) patients pretreated with one prior line of ROS1 tyrosine kinase inhibitor (TKI) with or without prior chemotherapy -- Potential best-in-class therapy for ROS1-positive metastatic NSCLC and NTRK-positive advanced solid tumors SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., June 10, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, g

  • Simply Wall St.

    What Kind Of Investors Own Most Of Zai Lab Limited (NASDAQ:ZLAB)?

    If you want to know who really controls Zai Lab Limited ( NASDAQ:ZLAB ), then you'll have to look at the makeup of its...